Generic Name and Formulations:
Acrivastine 8mg, pseudoephedrine HCl 60mg; caps.
- Low Relative Lymphocyte Count Associated With Higher Mortality in COPD
- Blood Pressure Reduced With Supplemental Oxygen in Obstructive Sleep Apnea
- D-Dimer Shows Promise for Pulmonary Embolism Diagnosis in Adolescents
Indications for SEMPREX-D:
Seasonal allergic rhinitis symptoms.
1 cap every 4–6hrs; max 4 caps/day.
Severe hypertension or coronary artery disease. During or within 14 days of MAOIs.
Hypertension. Diabetes. Ischemic heart disease. Increased intraocular pressure. Hyperthyroidism. Prostatic hypertrophy. Peptic ulcer. GI obstruction. Renal impairment (CrCl ≤48mL/minute): not recommended. Elderly. Pregnancy (Cat.B). Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Avoid concomitant CNS depressants, OTC antihistamines and decongestants, alcohol. Potentiated by beta agonists. Antagonizes antihypertensives.
Somnolence, dry mouth, nervousness, insomnia, ephedrine-like reactions (tachycardia, palpitations, headache, dizziness, nausea).